Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 210,045 $ 286,487
Accounts receivable, net 18,825 17,149
Other receivables, net 1,378 3,836
Inventories, net 28,230 24,573
Prepaid expenses and other current assets 4,059 4,737
Contract assets 4,305 3,576
Total current assets 266,842 340,358
Property, plant and equipment, net 364,635 316,181
Intangible assets, net 83,578 84,659
Goodwill 62,663 62,649
Right-of-use assets 19,179 19,240
Leverage loans receivable 13,408 13,408
Restricted cash 480 481
Loan fees 1,452 1,397
Other assets 228 224
Total assets 812,465 838,597
Current liabilities    
Accounts payable 17,076 20,790
Accrued liabilities 14,042 18,777
Unearned revenue and contract liabilities 214
Current portion of lease liability 3,337 3,337
Current portion of long-term debt, net 218 357
Total current liabilities 34,673 43,475
Private warrants liability 4,583 9,578
Long-term lease liability, net 22,554 22,693
Long-term debt, net 261,459 260,934
Deferred income taxes 723 1,014
Other long-term liabilities 526 638
Total liabilities 324,518 338,332
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized: 100,760,215 and 100,687,820 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 10 10
Additional paid-in capital 633,213 619,145
Accumulated deficit (145,276) (118,890)
Total stockholders’ equity 487,947 500,265
Total liabilities and stockholders’ equity $ 812,465 $ 838,597